Cargando…
The role of avelumab in advanced urothelial carcinoma in the context of a dynamic treatment landscape
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797653/ https://www.ncbi.nlm.nih.gov/pubmed/35117082 http://dx.doi.org/10.21037/tcr.2018.12.04 |
_version_ | 1784641603611131904 |
---|---|
author | Koshkin, Vadim S. Basu, Arnab Grivas, Petros |
author_facet | Koshkin, Vadim S. Basu, Arnab Grivas, Petros |
author_sort | Koshkin, Vadim S. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8797653 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | AME Publishing Company |
record_format | MEDLINE/PubMed |
spelling | pubmed-87976532022-02-02 The role of avelumab in advanced urothelial carcinoma in the context of a dynamic treatment landscape Koshkin, Vadim S. Basu, Arnab Grivas, Petros Transl Cancer Res Editorial AME Publishing Company 2019-03 /pmc/articles/PMC8797653/ /pubmed/35117082 http://dx.doi.org/10.21037/tcr.2018.12.04 Text en 2019 Translational Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/. |
spellingShingle | Editorial Koshkin, Vadim S. Basu, Arnab Grivas, Petros The role of avelumab in advanced urothelial carcinoma in the context of a dynamic treatment landscape |
title | The role of avelumab in advanced urothelial carcinoma in the context of a dynamic treatment landscape |
title_full | The role of avelumab in advanced urothelial carcinoma in the context of a dynamic treatment landscape |
title_fullStr | The role of avelumab in advanced urothelial carcinoma in the context of a dynamic treatment landscape |
title_full_unstemmed | The role of avelumab in advanced urothelial carcinoma in the context of a dynamic treatment landscape |
title_short | The role of avelumab in advanced urothelial carcinoma in the context of a dynamic treatment landscape |
title_sort | role of avelumab in advanced urothelial carcinoma in the context of a dynamic treatment landscape |
topic | Editorial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797653/ https://www.ncbi.nlm.nih.gov/pubmed/35117082 http://dx.doi.org/10.21037/tcr.2018.12.04 |
work_keys_str_mv | AT koshkinvadims theroleofavelumabinadvancedurothelialcarcinomainthecontextofadynamictreatmentlandscape AT basuarnab theroleofavelumabinadvancedurothelialcarcinomainthecontextofadynamictreatmentlandscape AT grivaspetros theroleofavelumabinadvancedurothelialcarcinomainthecontextofadynamictreatmentlandscape AT koshkinvadims roleofavelumabinadvancedurothelialcarcinomainthecontextofadynamictreatmentlandscape AT basuarnab roleofavelumabinadvancedurothelialcarcinomainthecontextofadynamictreatmentlandscape AT grivaspetros roleofavelumabinadvancedurothelialcarcinomainthecontextofadynamictreatmentlandscape |